High-ranking OpenAI employees have reportedly met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT to be used to help determine which medications are approved and which medications are rejected by the FDA.
https://www.wired.com/story/openai-fda-doge-ai-drug-evaluation/
